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The common 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism causes decreased activity
of this enzyme and can be associated with mild-to-moderate hyperhomocysteinemia in homozygotes, particularly
when there is folic acid deficiency, as well as with vascular dementia, arterial thrombosis, venous thrombosis, neural-
tube defects, and fetal loss. When folic acid intake is sufficient, homozygotes for MTHFR 677T appear to be
protected against colon cancer and acute lymphatic leukemia, and fetuses bearing this genotype have an augmented
survival. The distribution of MTHFR 677T is worldwide, but its frequency in different populations varies exten-
sively. In the present study, we addressed the question of whether the MTHFR 677T alteration has an ancestral
origin or has occurred repeatedly. We analyzed the frequency distribution of the previously described polymorphism
A1298C in exon 7 and of three intronic dimorphisms, in white Israelis (Jews and Arabs), Japanese, and Ghanaian
Africans. The 677T allele was, remarkably, associated with one haplotype, G-T-A-C, in white and Japanese ho-
mozygotes. Among the Africans, analysis of maximum likelihood also disclosed an association with the G-T-A-C
haplotype, although none of the 174 subjects examined was homozygous for MTHFR 677T. These results suggest
that the MTHFR 677T alteration occurred on a founder haplotype that may have had a selective advantage.
The enzyme 5,10-methylenetetrahydrofolate reductase
(MTHFR [MIM 236250]) catalyzes the conversion of
5,10-methylenetetrahydrofolate (methylene-THF) to
5-methyltetrahydrofolate, which is the carbon donor for
methylation of homocysteine to methionine (Rosenblatt
and Fenton 2001). The human gene for MTHFR has
been mapped to chromosomal region 1p36.3 and con-
sists of ∼17 kb, which include 11 exons spanning 2.2
kb (cDNA GenBank accession number U09806) (Goy-
ette et al. 1994, 1998). A common alteration in the
MTHFR gene, C677T (dbSNP cluster ID rs1801133),
converts an alanine to a valine at position 222 and is
associated with reduced specific activity and increased
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thermolability of the enzyme, causing mild hyperhomo-
cysteinemia in homozygotes (Frosst et al. 1995). Ho-
mozygosity for MTHFR 677T was shown to increase
the risk of neural-tube defects and vascular dementia
(van der Put et al. 1997; Yoo et al. 2000), and, according
to some—but not all—studies, to confer a risk of arterial
and venous thrombosis (Brattstrom et al. 1998; Gem-
mati et al. 1999). These deleterious effects contrast with
the possible protective effects of MTHFR 677T homo-
zygosity against colon cancer and acute lymphatic leu-
kemia (Ma et al. 1997; Skibola et al. 1999; Wiemels et
al. 2001). The protective effect is probably related to
the contribution of methylene-THF to proper DNA syn-
thesis, in that it provides a methyl group for the con-
version of dUMP to dTMP, thereby preventing misin-
corporation of dUMP into DNA, which can cause
double-strand DNA breaks (Blount et al. 1997).
The frequency of the MTHFR 677T allele varies sub-
stantially in different regions of the world and among
ethnic groups. For example, the allele frequency is 0.07
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Table 1
Conditions for Identification of Three Novel Polymorphisms in the MTHFR Gene
LOCATION
PRIMER
FRAGMENT
LENGTH
(bp)
ANNEALING
TEMPERATURE
(C)
RESTRICTION
ENZYMEForward Reverse
Intron 2 TCCTCTTCCCACTGGTCACC GGCCTGAAGAACATCATGGCG 893 61 PaeI
Intron 6 CTTGTCTCAATTCTCTGTCCC TCCCGCTCCCAAGAACAAACATa 222 59 AflIII
Intron 10 CGTAGTGGATCCCGTCAGC CCACCGCTCAATCCACAGG 371 61 MnlI
a The underlined letter denotes a modified base necessary for the creation of an AflIII recognition site.
Table 2
Allele Frequencies of Five Polymorphisms in the MTHFR Gene in Whites, Japanese, and Africans
POLYMORPHISM
LOCATION
NUCLEOTIDE
ALTERATIONa
DISTANCE
FROM nt677b
(bp)
ALLELE FREQUENCY (95% CI) INc
Whites
( )Np 376
Japanese
( )Np 164
Africans
( )Np 348
Intron 2 533GrA 4,305 .65* (.6–.7) .88 (.81–.92) .62* (.57–.66)
Exon 4 677CrT 0 .34* (.29–.39) .42* (.34–.50) .08 (.06–.12)
Intron 6 31CrT 1,618 .49 (.44–.54) .75 (.68–.81) .39 (.34–.44)
Exon 7 1298ArC 1,902 .64 (.59–.69) .79 (.72–.85) .91 (.88–.94)
Intron 10 262CrG 5,378 .69 (.64–.73) .81 (.74–.87) .91 (.87–.93)
a Underlined bases denote the alleles for which the frequency is given. The nucleotide numbers in
exons 4 and 7 were derived from the human cDNA sequence reported by Goyette et al. (1994). The
nucleotide numbers in introns indicate their distance (in bp) from the 5′ boundaries of the respective
introns.
b Distance calculated in accordance with Entrez-Nucleotide Database (locus gi 17444393).
c N represents the number of alleles examined. Asterisks (*) indicate nonsignificant differencesbetween
the depicted alleles, whereas allele frequencies without an asterisk represent a significant ( )P  .01
difference from the frequency in the other populations.
in sub-Saharan Africans and 0.06 in Canadian Inuit,
whereas in whites, Japanese, and Chinese, the allele fre-
quencies are 0.24–0.54 (Hegele et al. 1997; Pepe et al.
1998). Interestingly, a north-to-south increase in allele
frequency has also been observed in Europe (Botto and
Yang 2000).
The variable distribution of the MTHFR C677T tran-
sition and the pathophysiological importance of the
MTHFR gene alteration prompted us to address the
question of whether MTHFR C677T is a recurrent mu-
tation or has a common ancestral origin. We hypothe-
sized that if C677T alteration occurred many times, it
would not be associated with specific intronic polymor-
phisms throughout the gene. If, however, a conserved
haplotype is present for the MTHFR 677T allele in sep-
arate populations, it could suggest either an ancestral
origin, a selective advantage, or both. To address these
questions, we analyzed novel and previously described
MTHFR polymorphisms in white, African, and Japanese
subjects.
Blood samples were obtained from 188 white Israelis
(Jews and Arabs), 82 Japanese, and 174 Ghanaian Af-
ricans, all unselected. Genomic DNA was isolated from
whole blood or was extracted from dried blood drops
mounted on cards (GENERATION; Gentra). All sub-
jects gave their informed consent, and the study was
approved by the institutional review boards in Israel,
Japan, and Ghana.
A search for intronic polymorphisms bymeans of PCR
amplification and direct sequencing of introns 2, 5–7,
and 10 identified three new polymorphisms: nucleotide
(nt) 533GrA in intron 2, nt31CrT in intron 6 (recently
introduced to the dbSNP database as rs1994798), and
nt262CrG in intron 10. Conditions for detection of
these polymorphisms by PCR amplification and restric-
tion-enzyme digestion are shown in table 1. The two
knownMTHFR polymorphisms, 677CrT in exon 4 and
1298ArC in exon 7 (dbSNP cluster ID rs1801131) were
detected as described elsewhere (Frosst et al. 1995;Weis-
berg et al. 1998).
The frequencies of all MTHFR polymorphisms in the
whites, Japanese, and Africans are presented in table 2.
Differences in the frequencies of the polymorphisms in
the three populations examined were determined by a
two-tailed Fisher’s exact test with 95% confidence in-
tervals (CIs) (GraphPad Software). As in previous studies
(Pepe et al. 1998; Botto and Yang 2000), we found a
significant difference in the frequency of the MTHFR
C677T polymorphism between Africans and non-Afri-
cans. Whereas the frequency of the 677T allele in whites
and Japanese was similar (0.34 and 0.42, respectively;
), the frequency in Africans (0.08) was signifi-Pp .08
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Table 3
Allele Frequencies of Four MTHFR Polymorphisms Associated with the 677C and 677T Alleles in
White and Japanese Individuals Homozygous for these Alleles
LOCATION
NUCLEOTIDE
POLYMORPHISMa
ALLELE FREQUENCY (95% CI) INb
Whites Japanese
677C
( )Np 262
677T
( )Np 404
677C
( )Np 50
677T
( )Np 82
Intron 2 533 GrA .54 (.47–.60) .998 (.987–.999) .79 (.65–.90) 1.00 (.95–1.00)
Intron 6 31 CrT .32 (.26–.38) .979 (.96–.99) .60 (.45–.74) .95 (.88–.99)
Exon 7 1298 ArC .52 (.46–.58) .998 (.987–.999) .64 (.49–.77) .988 (.93–.999)
Intron 10 262 CrG .57 (.50–.63) .997 (.987–.999) .76 (.62–.87) .95 (.88–.99)
a Underlined bases denote the alleles for which the frequency is given.
b N denotes the number of alleles examined. Differences in allele frequencies within each population
are significant at , with the exception of the intron-10 262CrG polymorphism in the JapaneseP ! .0001
population, for which .Pp .0018
Table 4
Frequency Distribution of Haplotypes in MTHFR 677C and 677T Alleles
HAPLOTYPEa
HAPLOTYPE FREQUENCY  SD INb
Whites Japanese Africans
677C
( )Np 250
677T
( )Np 126
677C
( )Np 95
677T
( )Np 69
677C
( )Np 319
677T
( )Np 29
G-T-A-C .255.04 .984.106 .66.09 .97.13 .30.03 1.00.31
A-C-C-G .43.04 0 .17.06 0 0 0
A-C-A-C .02.01 0 0 0 .30.03 0
G-C-A-C .075.025 .016.016 .04.03 .03.03 .27.03 0
A-C-A-G .06.02 0 0 0 0 0
G-C-C-G .06.02 0 0 0 .02.01 0
G-T-C-C .02.01 0 0 0 0 0
A-C-C-C .01.01 0 .09.04 0 0 0
G-C-C-C .035.016 0 .04.03 0 .05.016 0
A-T-A-C 0 0 0 0 .04.015 0
G-C-A-G 0 0 0 0 .01.007 0
G-T-A-G .035.016 0 0 0 0 0
a Each haplotype represents states at the four polymorphic sites: intron 2, intron 6, exon 7,
and intron 10.
b N denotes the number of alleles examined. Haplotype frequencies were estimated using the
maximum-likelihood method as implemented by the Arlequin software package. Differences in
frequencies within each population are significant at .P ! .0001
cantly lower ( ). There was also great variabili-P ! .0001
ty in the frequencies of the four additional MTHFR
polymorphisms.
For analysis of a possible association between the
677T or 677C allele and the other polymorphisms, we
also used DNA samples previously obtained from 202
white and 41 Japanese individuals homozygous for
MTHFR 677T and from 131 white and 25 Japanese
individuals homozygous for 677C (Seligsohn and Ziv-
elin 1997; Sonoda et al. 2000). Table 3 demonstrates
that, in whites and Japanese, there was a remarkable
association between the 677T allele and 533G in intron
2, 31T in intron 6, 1298A in exon 7, and 262C in intron
10. This finding defined a G-T-A-C haplotype that is
seemingly associated with the 677T allele. None of the
174 African subjects was homozygous for the 677T al-
lele, and, therefore, Africans could not be included in
this analysis. However, analysis of the data in Africans
by means of the maximum-likelihoodmethod employing
an expectation-maximization algorithm (Arlequin soft-
ware; Excoffier and Slatkin 1995) showed that the G-
T-A-C haplotype was significantly more common in as-
sociation with the 677T allele than with the 677C allele
( ). Table 4 summarizes the haplotype distri-P ! .0001
bution in the three populations, as estimated by themax-
imum-likelihood method, which, again, reveals a strong
association between MTHFR 677T and the G-T-A-C
haplotype. Another haplotype (A-C-C-G) was common
in whites and Japanese but was completely absent in
Africans, whereas two other haplotypes (A-C-A-C and
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G-C-A-C) were frequent in Africans but rare in whites
and Japanese. Taken together, the data suggest that the
strong association between the 677T allele and the G-
T-A-C haplotype stemmed from a founder effect, a
strong selective advantage, or both.
Several advantages and disadvantages of 677T ho-
mozygosity have been reported. Clearly, protection
against cancer could not have led to a significant ev-
olutionary advantage, nor could vascular thrombosis
or dementia constitute an evolutionary disadvantage.
Two recent studies suggest that there is a survival ad-
vantage in fetuses who are homozygotes for MTHFR
677T. A fourfold-higher frequency of homozygous
MTHFR 677T was observed in neonates in comparison
with aborted fetuses (Isotalo et al. 2000). Another
study from Spain showed that the prevalence of
MTHFR 677T homozygosity was significantly higher
in 0–20-year-old subjects (0.26) than in 21–40-year-
old subjects (0.13) (Munoz-Moran et al. 1998). This
profound difference was attributed to the use, during
pregnancy, of folic acid, which became mandatory in
Spain 20 years prior to the time of the study. In con-
trast, other studies demonstrated that 677T homozy-
gosity in pregnant women was associated with recur-
rent early and late fetal loss, probably because of
hyperhomocysteinemia in the absence of folic acid sup-
plementation (Wouters et al. 1993; Nelen et al. 1997;
Gris et al. 1999; Rosenblatt and Whitehead 1999).
Taken together, these data suggest that there may be
an overall survival advantage for fetuses homozygous
for the 677T allele, when their mothers take sufficient
folic acid during pregnancy.
The above considerations make it likely that adequate
folic acid intake in a given population may give rise to
an increase in the frequency of the MTHFR 677T allele,
whereas an inadequate intake may result in decreased
frequency. In this regard, the north-to-south increase in
the prevalence of the MTHFR 677T allele in Europe is
of interest (Botto and Yang 2000) and may be influenced
by the apparent higher folic acid content in the food of
Mediterranean populations compared with northern Eu-
ropean populations. A similar gradient in the frequency
of the MTHFR 677T allele has been described in the
Americas. In the Inuit, the prevalence of the MTHFR
677T allele was 0.06, whereas in southern Amerindians
prevalences of 0.21–0.68 have been observed (Hegele et
al. 1997; Pepe et al. 1998); exceptions include the Tupi
Parakana tribe of Brazil and the Cayapa population of
Ecuador, in whom the prevalences were found to be 0.11
and 0.04, respectively (Botto and Yang 2000). Conceiv-
ably, the low frequency of MTHFR 677T in Africans is
also related to folate deficiency. Malnutrition and infec-
tious diseases impairing intestinal absorption of folic
acid are still common in Africa (Rosenblatt and White-
head 1999). Of note in this regard are the differences in
677T allele frequency between Africans and African
Americans; a frequency of 0.06 has been observed in
sub-Saharan Africans, and frequencies of 0.12–0.35
have been recorded in individuals of African descent
from North and South America (Langman et al. 1998;
Botto and Yang 2000). These differences may also stem
from a variable intake of folic acid but could be related
to population admixture.
Taken together, these data suggest that the MTHFR
677T alteration has occurred once on the G-T-A-C hap-
lotype. We hypothesize that MTHFR homozygosity
conferred a survival advantage in populations with ad-
equate folic acid consumption, which may explain the
currently observed variability in its prevalence in dif-
ferent populations.
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